- Home
- ASC vs EIKN Comparison
ASC vs EIKN Comparison
Compare ASC & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASC | EIKN |
|---|---|---|
| Founded | 2010 | 2019 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 751.7M | 631.0M |
| IPO Year | 2013 | 2026 |
Fundamental Metrics
Financial Performance| Metric | ASC | EIKN |
|---|---|---|
| Price | $19.81 | $7.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | $22.50 | ★ $24.60 |
| AVG Volume (30 Days) | 622.2K | ★ 626.1K |
| Earning Date | 11-04-2026 | 11-06-2026 |
| Dividend Yield | ★ 1.61% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $16.60 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.31 | $7.02 |
| 52 Week High | $20.03 | $16.50 |
Technical Indicators
Market Signals| Indicator | ASC | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 63.75 | 32.44 |
| Support Level | $16.91 | $7.02 |
| Resistance Level | $20.03 | $10.20 |
| Average True Range (ATR) | 0.64 | 0.54 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 89.73 | 12.21 |
Price Performance
Historical ComparisonAbout ASC Ardmore Shipping Corporation
Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The company markets its services directly to its customers and commercial pool operators and charters its vessels to them through a combination of spot, commercial pooling, and time-charter arrangements. The majority of its revenue is generated from spot voyages, which typically last less than three months.
About EIKN Eikon Therapeutics Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.